Sedatromin en es it fr

Sedatromin Brand names, Sedatromin Analogs

Sedatromin Brand Names Mixture

  • No information avaliable

Sedatromin Chemical_Formula

C26H28N2

Sedatromin RX_link

No information avaliable

Sedatromin fda sheet

Sedatromin msds (material safety sheet)

Sedatromin Synthesis Reference

No information avaliable

Sedatromin Molecular Weight

368.514 g/mol

Sedatromin Melting Point

No information avaliable

Sedatromin H2O Solubility

750 mg/L

Sedatromin State

Solid

Sedatromin LogP

5.63

Sedatromin Dosage Forms

No information avaliable

Sedatromin Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Sedatromin Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Sedatromin Absorption

No information avaliable

Sedatromin side effects and Toxicity

No information avaliable

Sedatromin Patient Information

No information avaliable

Sedatromin Organisms Affected

Humans and other mammals